Oracle Investment Management
Latest statistics and disclosures from Oracle Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are QDEL, ACOR, THOR, OPK, IRWD. These five stock positions account for 64.96% of Oracle Investment Management's total stock portfolio.
- Added to shares of HTWR (+$8.84B), NXTM (+$6.35B), IRWD (+$5.99B), PACB (+$4.64B), ELN (+$3.25B), GTIV (+$2.34B), KND (+$1.40B), HNSN (+$599.19M), Tesaro (+$445.79M).
- Started new stock positions in PACB, HTWR, KND, ELN.
- Reduced shares in these stocks: ACHN (-$2.04B), MAKO (-$541.43M), BIIB (-$137.72M), ARAY (-$92.80M), LTS (-$55.03M), MAPP (-$17.08M), AXK (-$15.11M), VVUS, HNT.
- Sold out of its positions in AXK, HNT, MAPP, VVUS.
- As of March 31, 2013, Oracle Investment Management has $394.27B in assets under management (AUM). Assets under management grew from a total value of $350.91M to $394.27B.
- Independent of market fluctuations, Oracle Investment Management was a net buyer by $30.96B worth of stocks in the most recent quarter.
Oracle Investment Management portfolio companies for quarter ending March 2013
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| QDEL | Quidel Corporation | 19.77 | 3281557 | 23750.00 | 25.27 | |
| ACOR | Acorda Therapeutics | 16.22 | 1996468 | 32030.00 | 34.17 | |
| THOR | Thoratec Corporation | 14.15 | 1487349 | 37498.00 | 31.85 | |
| OPK | Opko Health | 9.79 | 5057292 | 7630.00 | 7.18 | |
| IRWD | Ironwood Pharmaceuticals | 5.04 | +43.00% | 1086018 | 18285.00 | 12.14 |
| GTXI | GTx | 4.23 | 4020003 | 4150.00 | 6.92 | |
| HNSN | Hansen Medical | 4.22 | +3.00% | 8278253 | 2010.00 | 1.62 |
| GTIV | Gentiva Health Services | 4.10 | +16.00% | 1493613 | 10820.00 | 11.72 |
| Tesaro | 3.77 | +3.00% | 677112 | 21960.10 | 0.00 | |
| ARAY | Accuray Incorporated | 3.38 | 2868425 | 4640.00 | 5.89 | |
| NXTM | NxStage Medical | 3.09 | +109.00% | 1078840 | 11280.00 | 14.47 |
| MAKO | MAKO Surgical | 2.84 | -4.00% | 1003513 | 11150.00 | 12.24 |
| HTWR | HeartWare International | 2.24 | NEW | 100000 | 88406.00 | 93.66 |
| Transition Therapeutics | 1.96 | 3586497 | 2150.00 | 0.00 | ||
| ACHN | Achillion Pharmaceuticals | 1.46 | -26.00% | 657897 | 8750.00 | 7.99 |
| PACB | Pacific Biosciences of California | 1.18 | NEW | 1865000 | 2490.00 | 2.79 |
| ELN | Elan Corporation | 0.82 | NEW | 275000 | 11800.00 | 13.76 |
| MBLX | Metabolix | 0.77 | 1658126 | 1830.00 | 1.52 | |
| BIIB | Biogen Idec | 0.57 | -5.00% | 11603 | 192618.03 | 208.43 |
| KND | Kindred Healthcare | 0.36 | NEW | 133000 | 10530.00 | 13.57 |
| LTS | Ladenburg Thalmann Financial Services | 0.07 | -16.00% | 166849 | 1660.00 | 1.62 |
Past 13F-HR SEC Filings for Oracle Investment Management
- Oracle Investment Management 2012 Q4 - filed Feb. 14, 2013
- Oracle Investment Management 2012 Q3 amended - filed Dec. 3, 2012
- Oracle Investment Management 2012 Q3 - filed Nov. 14, 2012
- Oracle Investment Management 2012 Q2 - filed Aug. 14, 2012
- Oracle Investment Management 2012 Q1 - filed May 3, 2012
- Oracle Investment Management 2011 Q4 - filed Feb. 10, 2012
- Oracle Investment Management 2011 Q3 - filed Nov. 4, 2011
- Oracle Investment Management 2011 Q2 - filed Aug. 8, 2011
- Oracle Investment Management 2011 Q1 - filed May 4, 2011
- Oracle Investment Management 2010 Q4 - filed Feb. 10, 2011